T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity National Information Services
FIS
|
+$3.15B |
| 2 |
Global Payments
GPN
|
+$2B |
| 3 |
NextEra Energy
NEE
|
+$1.82B |
| 4 |
Salesforce
CRM
|
+$1.51B |
| 5 |
Boeing
BA
|
+$1.38B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WP
Worldpay, Inc.
WP
|
+$3.23B |
| 2 |
DATA
Tableau Software, Inc.
DATA
|
+$1.76B |
| 3 |
TSS
Total System Services, Inc.
TSS
|
+$1.49B |
| 4 |
Bank of America
BAC
|
+$1.43B |
| 5 |
Elevance Health
ELV
|
+$1.39B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.68% |
| 2 | Healthcare | 15.83% |
| 3 | Financials | 13.92% |
| 4 | Consumer Discretionary | 13.43% |
| 5 | Industrials | 10.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Healthpeak Properties
DOC
$14.3B
| $30.4M | ﹤0.01% |
852,373
-250,184
| -23% | -$8.45M |
|
1027
Regions Financial
RF
$27B
| $30.4M | ﹤0.01% |
1,919,451
+14,467
| +0.8% | +$219K |
|
1028
Labcorp
LH
$26.2B
| $30.4M | ﹤0.01% |
210,319
+386
| +0.2% | +$56.3K |
|
1029
AnaptysBio
ANAB
$1.66B
| $30.2M | ﹤0.01% |
864,204
-73,069
| -8% | -$3.48M |
|
|
ONCE
1030
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $29.9M | ﹤0.01% |
307,837
-386,859
| -56% | -$38.7M |
|
1031
Commault Systems
CVLT
$6.26B
| $29.8M | ﹤0.01% |
665,675
-9,354
| -1% | -$428K |
|
1032
Plains GP Holdings
PAGP
$5.04B
| $29.6M | ﹤0.01% |
1,393,016
-913,929
| -40% | -$21.1M |
|
|
GWR
1033
DELISTED
Genesee & Wyoming Inc.
GWR
| $29.5M | ﹤0.01% |
267,255
-1,287,204
| -83% | -$142M |
|
1034
A.O. Smith
AOS
$8.49B
| $29.5M | ﹤0.01% |
618,844
+24,011
| +4% | +$1.11M |
|
1035
Citizens Financial Group
CFG
$31.2B
| $29.3M | ﹤0.01% |
827,466
+766
| +0.1% | +$26.7K |
|
1036
HF Sinclair
DINO
$16.3B
| $29.1M | ﹤0.01% |
543,105
+38,787
| +8% | +$1.88M |
|
1037
Best Buy
BBY
$18B
| $29.1M | ﹤0.01% |
421,623
-5,086
| -1% | -$355K |
|
1038
Amcor
AMCR
$21.4B
| $28.9M | ﹤0.01% |
593,666
+7,882
| +1% | +$407K |
|
1039
Waters Corp
WAT
$40.6B
| $28.9M | ﹤0.01% |
129,397
-1,378
| -1% | -$297K |
|
1040
CRISPR Therapeutics
CRSP
$5.22B
| $28.6M | ﹤0.01% |
698,243
-40,626
| -5% | -$1.94M |
|
1041
Extra Space Storage
EXR
$31.6B
| $28.6M | ﹤0.01% |
244,522
+8,460
| +4% | +$978K |
|
1042
Mid-America Apartment Communities
MAA
$15.6B
| $28.5M | ﹤0.01% |
219,296
+440
| +0.2% | +$54.7K |
|
|
GHDX
1043
DELISTED
Genomic Health, Inc.
GHDX
| $28.5M | ﹤0.01% |
419,848
-8,685
| -2% | -$596K |
|
|
HBMD
1044
DELISTED
Howard Bancorp, Inc. Common Stock
HBMD
| $28.1M | ﹤0.01% |
1,682,767
+119,100
| +8% | +$1.8M |
|
1045
First Hawaiian
FHB
$3.39B
| $28M | ﹤0.01% |
1,049,727
+19,632
| +2% | +$509K |
|
1046
Jazz Pharmaceuticals
JAZZ
$16B
| $28M | ﹤0.01% |
218,399
+7,087
| +3% | +$950K |
|
1047
Agnico Eagle Mines
AEM
$91.3B
| $28M | ﹤0.01% |
521,508
-11,706
| -2% | -$663K |
|
1048
Barclays
BCS
$94.6B
| $27.8M | ﹤0.01% |
3,784,637
-137,537
| -4% | -$995K |
|
|
ODT
1049
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $27.8M | ﹤0.01% |
1,066,320
+23,874
| +2% | +$799K |
|
1050
Delek US
DK
$4.18B
| $27.7M | ﹤0.01% |
763,860
+734,650
| +2,515% | +$27M |
|
Similar funds
T. Rowe Price Associates's Q3 2019 Portfolio in Review
As of Q3 2019, T. Rowe Price Associates held 2,592 positions worth $706B, down 0.8% from $712B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Trading was light in Q3 2019: portfolio turnover was 4.9%. T. Rowe Price Associates opened 52 new positions and exited 74, leaving the 2,592-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2019 buy was The Southern Company: 9,440,159 shares worth $502M.
- T. Rowe Price Associates added most to Fidelity National Information Services in Q3 2019, an estimated $3.15B increase.
- T. Rowe Price Associates's biggest Q3 2019 reduction was Bank of America, cutting an estimated $1.43B.
- T. Rowe Price Associates fully exited Worldpay, Inc. in Q3 2019, selling an estimated $3.23B.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $706B portfolio in Q3 2019.
- T. Rowe Price Associates opened 52 new positions and closed 74 in Q3 2019.
- T. Rowe Price Associates's portfolio value fell 0.8% quarter-over-quarter to $706B.
Based on T. Rowe Price Associates's 13F filing for Q3 2019, filed 14 Nov 2019.